Generated Narrative: StructureDefinition Chemotherapy Name Flags Card. Type Description & Constraints Chemotherapy 0..* Base Chemotherapy #xD; relatedDiagnosis 1..1 Identifier Related Diagnosis #xD; startDate 1..1 dateTime Start date #xD; endDate 1..1 dateTime End date #xD; istitutionOfTreatment 0..1 BackboneElement Institution of treatment #xD; description 0..1 string Institution description #xD; name 0..1 string Institution name #xD; address 0..1 BackboneElement Institution address #xD; name 0..1 string Institution city #xD; country 0..1 string Institution country #xD; productAdministration 1..20 BackboneElement Product(s) administartion data #xD; <a href="StructureDefinition-Chemotherapy-definitions.html#Chemotherapy.productAdministration.agent" title="In this section, any of the 'antineoplastic and immunostimulating agents' received by the survivor should be reported, Drugs names are reported based on the ATC code listed under L01 to L04 in Appendix. Synonyms are included. When you start typing the name of the drug, the possible options will automatically suggested by the system. #xA;Up to 20 drugs are allowed into the system. The variable acronym changes based on the ordinal cmulative number of drugs received (e.g. FN_1, FN_2, FN_3, ?)">agent 1..1 CodeableConcept Antineoplastic and immunostimulating agents #xD; dose 0..1 Quantity Dose (NOT in PCSP DB) #xD; cumulativeDose 0..1 BackboneElement Cumulative Dose #xD; notAvailable 0..1 CodeableConcept Not calculated or not known dose #xD; measureType 0..1 CodeableConcept How the dose was determined (estimation or calculation) #xD; completionStatus 0..1 CodeableConcept The reported doses are incomplete (either under- or over-estimated) #xD; statusReason 0..1 string Specify reasons why #xD; value 0..1 decimal Total cumulative dose #xD; mg/m2#xA;2 => gr/m2#xA;3 => UI/m2#xA;4 => NK#xA;5 => NC (not calculated)">unit 0..1 CodeableConcept Measure unit #xD; Yes#xA;2 => No#xA;-9922 => NK">corticosteroids 0..1 CodeableConcept Prolonged corticosteroids as anti-cancer treatment at least 4 weeks continuously #xD; intrathecalInjections 0..1 BackboneElement Intrathecal injections #xD; Yes#xA;2 => No#xA;-9922 => NK">status 0..1 CodeableConcept Did the survivor receive therapeutic intrathecal injections ? #xD; number 0..1 integer Total number #xD; productName 0..* string Drug(s) administered #xD; otherTreatments 0..1 BackboneElement Other chemothrapeutic treatments #xD; productName 1..* string Drugs name #xD; Documentation for this format
Chemotherapy model to PCSP HL7 FHIR R4 Profiles
Identifier of the diagnosis for which this chemotherapy is performed
Please report the date of the first chemotherapy given. If the date is unkown or partially missed insert the year at the best of your knowledge.
Please report the date of the last chemotherapy given. If the date is unkown or partially missed insert the year at the best of your knowledge.
Please indicate the institution in which all or most of the chemotherapeutic treatment was given
All FHIR elements must have a @value or children
hasValue() or (children().count() > id.count())
Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.
Extensions are always sliced by (at least) url
Additional content defined by implementations
May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.
There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.
Must have either extensions or value[x], not both
exists(f:extension)!=exists(f:*[starts-with(local-name(.), "value")])
Extensions that cannot be ignored even if unrecognized
May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself).
Modifier extensions allow for extensions that *cannot* be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the [definition of modifier extensions](http://hl7.org/fhir/R4/extensibility.html#modifierExtension).
Modifier extensions are expected to modify the meaning or interpretation of the element that contains them
Please provide name, city and countryof the institution
Information about the product(s) administered
Antineoplastic and immunostimulating agents
In this section, any of the 'antineoplastic and immunostimulating agents' received by the survivor should be reported, Drugs names are reported based on the ATC code listed under L01 to L04 in Appendix. Synonyms are included. When you start typing the name of the drug, the possible options will automatically suggested by the system. Up to 20 drugs are allowed into the system. The variable acronym changes based on the ordinal cmulative number of drugs received (e.g. FN_1, FN_2, FN_3, ?)
Dose received of each drug for this administration
Report the total cumulative dose received of each drug.
Flag indicating if the dose was not calculated or it was not known
.valueCodeableConcept = http://terminology.hl7.org/CodeSystem/data-absent-reason#unknown
How the dose was determined (estimation or calculation)
Specify if the cumulative dose reported has been all calculated on real data or estimated based on the expected dose prescribed by the protocol. If some part of the calculation was based on estimated values, the whole field should be 'estimated'
The reported doses are incomplete (either under- or over-estimated)
Specify reasons of incomplete estimated doses
If the dose was calculated, please report the measure unit of the calculation 1 => mg/m2 2 => gr/m2 3 => UI/m2 4 => NK 5 => NC (not calculated)
Prolonged corticosteroids as anti-cancer treatment at least 4 weeks continuously
Report 'yes' if the survivor was treated with steroids for at least 4 weeks continuously 1 => Yes 2 => No -9922 => NK
MedicationStatement.where(medicationCodeableConcept = 'http://www.whocc.no/atc|H02' and dosage.timing.repeat.boundsDuration.where( value='4' and code = 'w' and comparator ='>' )
MedicationStatement.where(dosage.route = https://standardterms.edqm.eu|20042000)
Did the survivor receive therapeutic intrathecal injections ?
Please state if the survivor received any therapeutic intrathecal injections 1 => Yes 2 => No -9922 => NK
Please report the names of drugs injected intrathecal
Report any other chemothrapeutic treatments that are not included in the ATC code